Vertex to Participate in Upcoming September Investor Conferences
Vertex to Participate in Upcoming September Investor Conferences
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.BOSTON--(BUSINESS WIRE)--Aug. 22, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.
波士頓--(美國商業資訊)--2024年8月22日--Vertex Pharmicals Incorporated（納斯達克股票代碼：VRTX）今天宣佈管理層將參加兩次即將舉行的投資者會議。
- Dr. Reshma Kewalramani, Chief Executive Officer and President, and Charles Wagner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 11:30 a.m. ET.
- Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 9:10 a.m. ET.
- 首席執行官兼總裁雷什瑪·凱瓦爾拉馬尼博士和執行副總裁兼首席財務官查爾斯·瓦格納將於美國東部時間2024年9月5日星期四上午11點30分參加摩根士丹利第22屆年度全球醫療保健會議的爐邊談話。
- 投資者關係高級副總裁蘇西·麗莎和投資者關係執行董事馬尼莎·派將於美國東部時間2024年9月17日星期二上午9點10分參加坎託全球醫療大會的爐邊談話。
A live webcast of management's remarks will be available through the Vertex website, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.
管理層講話的網絡直播將通過Vertex網站的 「新聞和事件」 頁面下的 「投資者」 部分進行直播。會議網絡直播的重播將存檔在公司的網站上。
About Vertex
關於 Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Vertex 是一家全球生物技術公司，投資於科學創新，爲嚴重疾病患者創造變革性藥物。該公司已經批准了治療多種慢性、縮短壽命的遺傳疾病（囊性纖維化、鐮狀細胞病和依賴輸血的β地中海貧血）根本原因的藥物，並將繼續推進這些疾病的臨床和研究項目。Vertex還擁有強大的臨床研究療法產品線，涵蓋其他嚴重疾病的各種模式，對人類因果生物學有深刻的見解，包括急性和神經性疼痛、APOL1介導的腎臟疾病、IgA腎病、常染色體顯性多囊腎病、1型糖尿病、1型肌強直營養不良症和α-1抗胰蛋白酶缺乏症。
Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune's 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit or follow us on LinkedIn, Facebook, Instagram, YouTube and Twitter/X.
Vertex 成立於 1989 年，全球總部位於波士頓，國際總部設在倫敦。此外，該公司在北美、歐洲、澳大利亞、拉丁美洲和中東設有研發基地和商業辦事處。Vertex 一直被公認爲業內最佳工作場所之一，包括連續 14 年入選《科學》雜誌的 「傑出僱主」 榜單，併入選《財富》100家最佳工作公司之一。要了解公司最新動態並進一步了解Vertex的創新歷史，請在領英、臉書、Instagram、YouTube和Twitter/X上訪問或關注我們。
(VRTX-WEB)
（VRTX-WEB）
View source version on businesswire.com:
在 businesswire.com 上查看源版本：
Vertex Pharmaceuticals Incorporated
Vertex 製藥公司
Investors:
InvestorInfo@vrtx.com
投資者：
InvestorInfo@vrtx.com
Source: Vertex Pharmaceuticals Incorporated
來源：Vertex 製藥公司
